NCT00041236 2012-07-18
Exatecan Mesylate in Treating Patients With Advanced Soft Tissue Sarcoma
European Organisation for Research and Treatment of Cancer - EORTC
Phase 2 Completed
Clinical Trials
11 trialsNCT00003951 2012-05-16
DX-8951f in Treating Patients With Metastatic Cancer of the Pancreas
Daiichi Sankyo
Phase 2 Completed
NCT00004045 2012-05-16
Chemotherapy in Treating Patients With Prostate Cancer
Daiichi Sankyo
Phase 2 Completed
NCT00004046 2012-05-16
Chemotherapy in Treating Women With Metastatic Breast Cancer
Daiichi Sankyo
Phase 2 Completed
NCT00004060 2012-05-16
Chemotherapy in Treating Patients With Recurrent, Metastatic, or Unresectable Ovarian, Fallopian Tube, or Peritoneal Cancer
Daiichi Sankyo
Phase 2 Completed
NCT00004108 2012-05-16
DX-8951f in Treating Patients With Liver Cancer
Daiichi Sankyo
Phase 2 Completed
NCT00004866 2012-05-16
DX-8951f in Treating Women Who Have Advanced or Recurrent Cancer of the Cervix
Daiichi Sankyo
Phase 2 Completed
NCT00005938 2012-05-16
DX-8951f in Treating Patients With Biliary Cancer
Daiichi Sankyo
Phase 2 Completed
NCT00017212 2012-05-16
DX-8951f in Treating Patients With Metastatic Stomach Cancer
Daiichi Sankyo
Phase 2 Completed
NCT00055939 2012-05-16
Exatecan Mesylate in Treating Children With Relapsed or Refractory Rhabdomyosarcoma
Daiichi Sankyo
Phase 2 Completed
NCT00055952 2012-05-16
Exatecan Mesylate in Treating Patients With Ewing's Sarcoma, Primitive Neuroectodermal Tumor, or Desmoplastic Small Round Cell Tumor
Daiichi Sankyo
Phase 2 Completed